One year update on the COVID-19 pandemic: Where are we now?

SK Mishra, T Tripathi - Acta tropica, 2021 - Elsevier
We are living through an unprecedented crisis with the rapid spread of the new coronavirus
disease (COVID-19) worldwide within a short time. The timely availability of thousands of …

[PDF][PDF] The immunopathobiology of SARS-CoV-2 infection

M Patel, F Shahjin, JD Cohen, M Hasan… - FEMS Microbiology …, 2021 - academic.oup.com
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to
coronavirus disease 2019 (COVID-19). Virus-specific immunity controls infection …

COVID-19 associated complications and potential therapeutic targets

JD Monpara, SJ Sodha, PK Gupta - European Journal of Pharmacology, 2020 - Elsevier
The global pandemic COVID-19, caused by novel coronavirus SARS-CoV-2, has emerged
as severe public health issue crippling world health care systems. Substantial knowledge …

[HTML][HTML] The COVID-19 cytokine storm; what we know so far

D Ragab, H Salah Eldin, M Taeimah… - Frontiers in …, 2020 - frontiersin.org
COVID-19 is a rapidly spreading global threat that has been declared as a pandemic by the
WHO. COVID-19 is transmitted via droplets or direct contact and infects the respiratory tract …

Pathophysiology and treatment strategies for COVID-19

M Kumar, S Al Khodor - Journal of translational medicine, 2020 - Springer
The outbreak of Coronavirus disease of 2019 (COVID-19) caused by the Severe Acute
Respiratory Syndrome coronavirus 2 (SARS-CoV-2), has posed a serious health threat. The …

[PDF][PDF] Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2

K Negi, M Agarwal, I Pahuja, B Bhardwaj… - Oxford Open …, 2023 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes lethal
coronavirus disease (COVID-19). SARS-CoV-2 has been the chief source of threat to public …

SARS-CoV-2: pathogenesis, and advancements in diagnostics and treatment

K Khalaf, N Papp, JTT Chou, D Hana… - Frontiers in …, 2020 - frontiersin.org
The emergence and rapid spread of SARS-CoV-2 in December 2019 has brought the world
to a standstill. While less pathogenic than the 2002–2003 SARS-CoV, this novel …

Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to …

AA Rabaan, SH Al-Ahmed, J Muhammad, A Khan… - Vaccines, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …

COVID-19 and the immune response: A multi-phasic approach to the treatment of COVID-19

T Sapir, Z Averch, B Lerman, A Bodzin… - International Journal of …, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a viral agent that causes
Coronavirus disease 2019 (COVID-19), a disease that causes flu-like symptoms that, when …

[PDF][PDF] From SARS-CoV to SARS-CoV2: a potential guide to better understanding of pathophysiology of the disease and potential therapeutic modality.

PA Pashaki, MH Roudkenar, F Rahim… - European Review for …, 2020 - europeanreview.org
Currently, the outbreak and spread of coronavirus disease 2019 (COVID-19) caused by
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), are increasing …